CARLSBAD,A Calif. Bristol-Myers Squibb has paid Isis Pharmaceuticals a $6 million milestone payment for regulatory approval to begin an early-stage clinical trial of a cholesterol-lowering drug, Isis announced Monday.
189347 items (189347 unread) in 47 feeds
World Health Organization
(226 unread)
Media
(146550 unread)
Bird Flu
(3059 unread)
Diabetes
(8426 unread)
Cholesterol
(3564 unread)
Cancer
(15116 unread)
HIV
(7259 unread)
Women
(3814 unread)
Men
(1333 unread)
CARLSBAD,A Calif. Bristol-Myers Squibb has paid Isis Pharmaceuticals a $6 million milestone payment for regulatory approval to begin an early-stage clinical trial of a cholesterol-lowering drug, Isis announced Monday.
Pharmaceutical companies boosted their spending on ads directly targeting consumers by barely 2 percent last year, according to data compiled by The Nielsen Co.